These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3691606)

  • 1. Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man.
    Wilkens JH; Wilkens H; Elger B; Cassidy F; Caspary L; Creutzig A; Frölich JC
    Eur J Clin Pharmacol; 1987; 33(2):133-7. PubMed ID: 3691606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous infusion of prostacyclin (PGI2) or prostaglandin E1 (PGE1) in augmentation of skin flap blood flow and viability in the pig.
    Forrest CR; Pang CY; Zhong AG; Kreidstein ML
    Prostaglandins; 1991 Jun; 41(6):537-58. PubMed ID: 2052739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E1 increases myocardial contractility in the conscious dog.
    Roux S; Latour JG; Théroux P; Clozel JP; Bourassa MG
    Can J Physiol Pharmacol; 1984 Dec; 62(12):1505-10. PubMed ID: 6543330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phenylephrine and prostaglandin E1 on ventriculo-arterial matching during halothane anaesthesia.
    Hoka S; Kawasaki T; Okamoto H; Okuyama T; Takahashi S
    Br J Anaesth; 1995 Apr; 74(4):438-42. PubMed ID: 7734265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E1 attenuates the hypertensive response to tracheal extubation.
    Nishina K; Mikawa K; Shiga M; Maekawa N; Obara H
    Can J Anaesth; 1996 Jul; 43(7):678-83. PubMed ID: 8807172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome.
    Russell JA; Ronco JJ; Dodek PM
    Chest; 1990 Mar; 97(3):684-92. PubMed ID: 2306970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of intravenously applied prostaglandin E1.
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.
    Saeki S; Yamamura K; Matsushita M; Nishikimi N; Sakurai T; Nimura Y
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):525-9. PubMed ID: 9799055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral oxygenation during prostaglandin E1 induced hypotension.
    Kadoi Y; Saito S; Kunimoto F; Morita T; Goto F; Kawahara F; Fujita N
    Can J Anaesth; 1998 Sep; 45(9):860-4. PubMed ID: 9818109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effects of prostaglandin E1 and nitroglycerin on regional cerebral oxygenation in anesthetized patients.
    Kadoi Y; Saito S; Morita T; Imai T; Kawahara H; Fujita N; Goto F
    Anesth Analg; 1997 Nov; 85(5):1054-9. PubMed ID: 9356099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of stellate ganglion block with intravascular infusion of prostaglandin E1 on brachial artery blood flow in dogs.
    Okuda Y; Kitajima T
    Anesth Analg; 1997 Jun; 84(6):1329-32. PubMed ID: 9174315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
    Scheffler P; Gross J; Markwirth T; Maier J; Schieffer H
    Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
    Hasegawa H; Ichioka S
    J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
    Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
    Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.